M A Flores Selected Research

naxitamab-gqgk

6/2022	Corrigendum to "How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain": [ESMO Open, 7 (2022) 100462].
1/2022	How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M A Flores Research Topics

Disease

2	Neuroblastoma 06/2022 - 01/2022
1	Post-Dural Puncture Headache 01/2022
1	Pain (Aches) 01/2022
1	Overweight 01/2022
1	Body Weight (Weight, Body) 09/2001
1	Gallstones (Gallstone) 09/2001

Drug/Important Bio-Agent (IBA)

2	naxitamab-gqgkIBA 06/2022 - 01/2022
1	Ketamine FDA LinkGeneric 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	BilirubinIBA 09/2001
1	SaltsIBA 09/2001

Therapy/Procedure

1	Conservative Treatment 01/2022
1	Epidural Blood Patch 01/2022